Carcinogenicity and mutagenicity of malathion and its two analogues: a systematic review

Priscilla Luna Bastos1, Alyne Fernanda Tôrres de Lima Bastos1, Aline do Monte Gurgel2

  • 1Secretaria Estadual de Saúde de Pernambuco. R. Dona Maria Augusta Nogueira 519, Bongi. 50751-530 Recife PE Brasil. prilunab@gmail.com.

Ciencia & Saude Coletiva
|August 14, 2020
PubMed

Insights

Malathion, a probable human carcinogen, shows evidence of causing genetic damage and increasing cancer risk in women. Its use in arbovirus control warrants careful consideration due to these findings.

Area of Science:

  • Environmental Toxicology
  • Carcinogenesis Research
  • Public Health Entomology

Background:

  • Malathion is a widely used insecticide in global arbovirus control programs.
  • The International Agency for Research on Cancer classified malathion as a probable human carcinogen in 2015.
  • Concerns exist regarding the carcinogenic and mutagenic potential of malathion and its analogs.

Purpose of the Study:

  • To systematically review and synthesize existing scientific evidence on the carcinogenic and mutagenic effects of malathion exposure.
  • To evaluate data on malathion's analogs, specifically malaoxon and isomalathion.
  • To inform public health policies regarding the use of malathion in vector control.

Main Methods:

  • Comprehensive literature search conducted in Toxline, PubMed, and Scopus databases.
  • Inclusion of original research papers published between 1983 and 2015.
  • Selection of 73 relevant studies from an initial pool of 273 eligible papers.

Main Results:

  • In vitro and in vivo studies indicated that malathion primarily induces genetic and chromosomal damage.
  • Epidemiological studies revealed significant positive associations between malathion exposure and increased risk of thyroid, breast, and ovarian cancers in menopausal women.
  • Evidence suggests a link between malathion exposure and specific human cancers.

Conclusions:

  • The compiled evidence highlights the carcinogenic effects of malathion.
  • Findings underscore the need to reassess the risks versus benefits of using malathion in arbovirus control programs.
  • Further investigation into malathion's long-term health impacts is warranted.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.7K
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.0K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.7K